Objectives To determine if disease duration and number of prior disease-modifying antirheumatic drugs (DMARDs) affect response to therapy in patients with established rheumatoid arthritis (RA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback